Dispatches from AAPS
Peru's GMP requirements mean delayed approvals, says expert
Stricter GMP requirements in Peru are increasing the time it takes to get drugs approved and may not be giving regulators any useful additional information.
Archives for October 15, 2012
More discovery outsourcing at AstraZeneca with Pharmaron deal
Sino-US CRO Pharmaron has signed a drug discovery partnership with Anglo-Swedish drug major AstraZeneca.
Dispatches from AAPS
Remember regional Biosimilar regs and ref drugs differ, says Pfizer
Manufacturers trying to prove the similarity of their biosimilars must consider that regulations and reference medicines differ in different markets says Pfizer.
Clinical sites get their own industry group
A new trade organisation intended to give clinical research sites a voice was launched at industry event earlier this week.
Dispatches from AAPS
Emerging market CMOs and their customers must make info easily available: FDA
Make information about generic production readily available when working with vendors in emerging markets for quicker US approval, says the FDA.
SternMaid pumps cash into fluid bed processing
SternMaid has invested €14m in its Wittenburg factory to enlarge capacity and extend the range of its products and services, involving the introduction of new fluid bed technology.